Tags 3SBio Inc.

Tag: 3SBio Inc.

3SBio Signs Exclusive Patent License Agreement for DIG-KT, a Bi-Specific mAb...

3SBio Signs Exclusive Patent License Agreement for #dig-kt, a Bi-Specific #mab targeting VEGFR2 and Tie-2 with PharmAbcine DIG-KT is a novel bi-specific mAb targeting VEGFR2...

MOST POPULAR

HOT NEWS